Adrian Rawcliffe

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ Adrian Rawcliffe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adrian Rawcliffe:

Form 4 holding Chief Executive Officer, Director

Adaptimmune Therapeutics PLC

Security class
American Depositary Shares representing Ordinary Shares
Shares / value
44,327
Estimated value
$25,745
Report date
17 Jan 2025
Price
$0.5808
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

Adaptimmune Therapeutics PLC

Security class
Option to purchase Ordinary Shares
Shares / value
3,428,832
Estimated value
Report date
20 Feb 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Adrian Rawcliffe

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .